首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species
【2h】

Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species

机译:六个商业系统和全国临床检验标准委员会M27-A肉汤微稀释法对念珠菌Fluconazole敏感性测试的多中心比较评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fluconazole susceptibility among 800 clinical Candida isolates (60% C. albicans) and two control strains (C. krusei ATCC 6258 and C. parapsilosis ATCC 22019) was tested with the NCCLS M27-A method (gold standard) and six commercial products (Candifast, disk, Etest, Fungitest, Integral System Yeasts, and Sensititre YeastOne). Results were classified as susceptible, susceptible-dose dependent, or resistant using M27-A breakpoints or, for Fungitest, Integral System Yeasts, and Candifast, as susceptible, intermediate, or resistant, according to the manufacturers' instructions. Concordance with NCCLS M27-A results was analyzed with the χ2 test. Intra- and interlaboratory reproducibility was also evaluated. NCCLS M27-A (90.1%), Etest (93.1%), Sensititre YeastOne (93.1%), disk (96.7%), Fungitest (92.6%), Integral System Yeasts (40.6%), and Candifast (6.0%) classified the indicated percentages of C. albicans isolates as susceptible. Among non-C. albicans strains, the percentages of susceptible isolates were as follows: NCCLS M27-A, 74.0%; Etest, 83.8%; Sensititre YeastOne, 64.1%; disk, 60.6%; Fungitest, 76.6%; Integral System Yeasts, 28.3%; and Candifast, 27.4%. All methods except Candifast and Integral System Yeasts showed good agreement with NCCLS M27-A results for both C albicans and non-C. albicans isolates. Intralaboratory reproducibility was excellent for NCCLS M27-A, Etest, Sensititre YeastOne, disk, and Fungitest (88 to 91%). Similar results emerged from the interlaboratory reproducibility evaluation. Our findings indicate that some commercial methods can be useful for fluconazole susceptibility testing of clinical Candida isolates. Those characterized by a lack of medium standardization and/or objective interpretative criteria should be avoided. Particular caution is necessary when testing is being done for clinical and epidemiological purposes.
机译:使用NCCLS M27-A方法(黄金标准)和六种商业产品(Candifast)测试了800株临床念珠菌(60%白色念珠菌)和两种对照菌株(克鲁斯杆菌ATCC 6258和副念珠菌ATCC 22019)中的氟康唑敏感性。 ,磁盘,Etest,Fungitest,Integral System Yeasts和Sensititre YeastOne)。根据制造商的说明,使用M27-A断点将结果分类为敏感,敏感剂量依赖性或耐药,对于Fungitest,完整系统酵母和Candifast,结果归为敏感,中间或耐药。用χ 2 检验分析与NCCLS M27-A结果的一致性。还评估了实验室内和实验室间的可重复性。 NCCLS M27-A(90.1%),Etest(93.1%),Sensititre YeastOne(93.1%),磁盘(96.7%),Fungitest(92.6%),Integral System Yeasts(40.6%)和Candifast(6.0%)分类所示的白色念珠菌分离株百分数为易感。非C之中。在白色念珠菌菌株中,易感分离株的百分比如下:NCCLS M27-A,74.0%;测验83.8%; Sensititre YeastOne,64.1%;磁盘,60.6%; Fungitest,76.6%;整体酵母菌,28.3%; Candifast占27.4%。除Candifast和Integral System Yeasts外,所有方法均对白色念珠菌和非C念珠菌的NCCLS M27-A结果显示出良好的一致性。白色念珠菌。 NCCLS M27-A,Etest,Sensititre YeastOne,磁盘和Fungitest的实验室内重现性极佳(88%至91%)。实验室间可重复性评估也得出了类似的结果。我们的发现表明,某些商业方法可用于临床念珠菌分离株的氟康唑药敏试验。应避免那些缺乏中等标准化和/或客观解释标准的特征。当出于临床和流行病学目的进行测试时,必须特别小心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号